Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering - PubMed (original) (raw)
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering
A Miller et al. Proc Natl Acad Sci U S A. 1992.
Abstract
Oral administration of myelin basic protein (MBP) is an effective way of suppressing experimental autoimmune encephalomyelitis (EAE). We have previously shown that such suppression is mediated by CD8+ T cells, which adoptively transfer protection and suppress immune responses in vitro. In the present study we have found that modulator cells from animals orally tolerized to MBP produce a suppressor factor upon stimulation with MBP in vitro that is specifically inhibited by anti-transforming growth factor beta (TGF-beta) neutralizing antibodies. No effect was observed with antibodies to gamma interferon, tumor necrosis factor alpha/beta, or indomethacin. In addition, the active form of the type 1 isoform of TGF-beta 1 (TGF-beta 1) can be directly demonstrated in the supernatants of cells from animals orally tolerized to MBP or ovalbumin after antigen stimulation in vitro. Antiserum specific for TGF-beta 1 administered in vivo abrogated the protective effect of oral tolerization to MBP in EAE. Furthermore, injection of anti-TGF-beta 1 serum to nontolerized EAE animals resulted in an increase in severity and duration of disease. These results suggest that immunomodulation of EAE induced by oral tolerization to MBP and natural recovery mechanisms use a common immunoregulatory pathway that is dependent on TGF-beta 1. Implications of such an association are of therapeutic relevance to human autoimmune diseases and may help to explain one of the mechanisms involved in the mediation of active suppression by T cells.
Similar articles
- Treatment of autoimmune disease by oral tolerance to autoantigens.
Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N. Whitacre CC, et al. Clin Immunol Immunopathol. 1996 Sep;80(3 Pt 2):S31-9. doi: 10.1006/clin.1996.0139. Clin Immunol Immunopathol. 1996. PMID: 8811061 Review. - Oral tolerance in experimental autoimmune encephalomyelitis.
Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N. Whitacre CC, et al. Ann N Y Acad Sci. 1996 Feb 13;778:217-27. doi: 10.1111/j.1749-6632.1996.tb21130.x. Ann N Y Acad Sci. 1996. PMID: 8610975 Review.
Cited by
- A Perspective on Oral Immunotherapeutic Tools and Strategies for Autoimmune Disorders.
Shakya AK, Mallick B, Nandakumar KS. Shakya AK, et al. Vaccines (Basel). 2023 May 27;11(6):1031. doi: 10.3390/vaccines11061031. Vaccines (Basel). 2023. PMID: 37376420 Free PMC article. Review. - Collagen Supplementation for Joint Health: The Link between Composition and Scientific Knowledge.
Martínez-Puig D, Costa-Larrión E, Rubio-Rodríguez N, Gálvez-Martín P. Martínez-Puig D, et al. Nutrients. 2023 Mar 8;15(6):1332. doi: 10.3390/nu15061332. Nutrients. 2023. PMID: 36986062 Free PMC article. Review. - Regulatory T cell and macrophage crosstalk in acute lung injury: future perspectives.
Guan T, Zhou X, Zhou W, Lin H. Guan T, et al. Cell Death Discov. 2023 Jan 16;9(1):9. doi: 10.1038/s41420-023-01310-7. Cell Death Discov. 2023. PMID: 36646692 Free PMC article. Review. - Oral Tolerance Induced by Heat Shock Protein 65-Producing Lactococcus lactis Mitigates Inflammation in Leishmania braziliensis Infection.
Guerra PV, Andrade CM, Nunes IV, Gama BC, Tibúrcio R, Santos WLC, Azevedo VA, Tavares NM, Rebouças JS, Maiolii TU, Faria AMC, Brodskyn CI. Guerra PV, et al. Front Immunol. 2021 Jun 24;12:647987. doi: 10.3389/fimmu.2021.647987. eCollection 2021. Front Immunol. 2021. PMID: 34248935 Free PMC article. - Role of orally induced regulatory T cells in immunotherapy and tolerance.
Bertolini TB, Biswas M, Terhorst C, Daniell H, Herzog RW, Piñeros AR. Bertolini TB, et al. Cell Immunol. 2021 Jan;359:104251. doi: 10.1016/j.cellimm.2020.104251. Epub 2020 Nov 14. Cell Immunol. 2021. PMID: 33248367 Free PMC article. Review.
References
- J Exp Med. 1986 May 1;163(5):1037-50 - PubMed
- Cell. 1989 Jun 30;57(7):1073-81 - PubMed
- Proc Natl Acad Sci U S A. 1987 Sep;84(17):6020-4 - PubMed
- J Cell Physiol. 1989 Jan;138(1):79-86 - PubMed
- J Immunol. 1987 Jun 1;138(11):3817-23 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous